🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To demonstrate the superiority of the single pill combi...
Status
Completed
Location
Investigational Site Number :1560033
Start Date
2020-12-08
Trial ID
NCT04669041
Treatments Being Tested
AK102 is being developed for the treatment of HoFH. The study will be condu...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2019-05-13
Trial ID
NCT03933293
The investigator hypothesize that vytorin may improve vascular and insulin ...
Status
Completed
Location
Gil Medical Center
Start Date
2011-07
Trial ID
NCT01660945
This is a randomized, double-blind, placebo-controlled phase 3 clinical stu...
Status
Completed
Location
Peking University First Hospital
Start Date
2021-11-03
Trial ID
NCT05255094
This is a randomized, double-blind, placebo-controlled phase # clinical stu...
Status
Completed
Location
The Second Affiliated Hospital Zhejiang University School of Medicine
Start Date
2022-01-26
Trial ID
NCT05260411
The purpose of this study is to evaluate the efficacy and safety of AD-221 ...
Status
Completed
Location
Yonsei University Hospital
Start Date
2021-11-16
Trial ID
NCT05131997
This is a multicenter study to evaluate the safety and efficacy of ezetimib...
Status
Completed
Location
Multiple Locations
Start Date
2007-02-01
Trial ID
NCT00479713
The overall objective of the Cholesterol Lowering via Bempedoic Acid/Ezetim...
Status
Unknown
Location
Kaiser Permanente Northern California Division of Research
Start Date
2022-03
Trial ID
NCT05263778
Treatments Being Tested
The purpose of this study is to determine if Bempedoic Acid (BA) + Ezetimib...
Status
Completed
Location
PMG Research of McFarland
Start Date
2017-10-23
Trial ID
NCT03337308
Treatments Being Tested
The overall objective is to evaluate the efficacy and safety of ezetimibe (...
Status
Completed
Location
Multiple Locations
Start Date
2000-04-24
Trial ID
NCT03867318
Treatments Being Tested